Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases
暂无分享,去创建一个
[1] M. Kazakova,et al. Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives , 2022, International journal of molecular sciences.
[2] Timothy A. Miller,et al. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. , 2022, The New England journal of medicine.
[3] S. E. Tyler,et al. Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer’s disease , 2022, Natural Products and Bioprospecting.
[4] K. Landry,et al. Oral Dysbiosis and Neurodegenerative Diseases: Correlations and Potential Causations , 2022, Microorganisms.
[5] Jikai Liu. Antiaging agents: safe interventions to slow aging and healthy life span extension , 2022, Natural products and bioprospecting.
[6] G. Lopez,et al. Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism , 2022, International journal of molecular sciences.
[7] S. Buduru,et al. Oral Microbiome: Getting to Know and Befriend Neighbors, a Biological Approach , 2022, Biomedicines.
[8] Victor Tapias,et al. Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels , 2022, IBRO neuroscience reports.
[9] R. Fischer,et al. Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons , 2021, Nature Communications.
[10] A. Strasser,et al. Molecular mechanisms of cell death in neurological diseases , 2021, Cell Death & Differentiation.
[11] H. Rahimi,et al. Brain-derived neurotrophic factor (BDNF) variation to aerobic exercise and aloe vera intake in women with type 2 diabetes , 2021 .
[12] R. Itzhaki. Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelming Evidence against , 2021, Vaccines.
[13] Vincent Marcucci,et al. Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review , 2021 .
[14] P. Carlier,et al. Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget , 2021, Journal of neurochemistry.
[15] Sungtae Yoon,et al. Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease , 2021, Frontiers in Neuroscience.
[16] Jinfang Zhu,et al. Recent advances in understanding the Th1/Th2 effector choice , 2021, Faculty reviews.
[17] K. Luk,et al. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease , 2021, JCI insight.
[18] N. Jana,et al. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington’s Disease , 2021, Molecular Neurobiology.
[19] C. Balducci,et al. Accelerating Alzheimer’s disease drug discovery and development: what’s the way forward? , 2021, Expert opinion on drug discovery.
[20] A. Laguna,et al. New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota , 2021, Biomolecules.
[21] R. Bauer,et al. Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.
[22] K. Kurz,et al. The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota , 2021, Nutrients.
[23] Jin-Ming Yang,et al. DNA Repair Pathways in Cancer Therapy and Resistance , 2021, Frontiers in Pharmacology.
[24] T. Vos,et al. Estimating the global mortality from Alzheimer’s disease and other dementias: A new method and results from the Global Burden of Disease study 2019 , 2020, Alzheimer's & Dementia.
[25] S. A. Naqvi,et al. Calotropis procera (root) escalates functions rehabilitation and attenuates oxidative stress in a mouse model of peripheral nerve injury. , 2020, Pakistan journal of pharmaceutical sciences.
[26] A. Tsatsakis,et al. Curcumin Formulations and Trials: What’s New in Neurological Diseases , 2020, Molecules.
[27] R. Pettigrew,et al. Achieving healthy human longevity: A global grand challenge , 2020, Science Translational Medicine.
[28] C. Blizzard,et al. Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex , 2020, Journal of neurochemistry.
[29] Chongming Wu,et al. The Gut Microbiota-Produced Indole-3-Propionic Acid Confers the Antihyperlipidemic Effect of Mulberry-Derived 1-Deoxynojirimycin , 2020, mSystems.
[30] R. Ghemrawi,et al. Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases , 2020, International journal of molecular sciences.
[31] R. León,et al. When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration , 2020, Antioxidants.
[32] Marwa I Ezzat,et al. Neuroprotective effects of Pulicaria undulata essential oil in rotenone model of parkinson's disease in rats: Insights into its anti-inflammatory and anti-oxidant effects , 2020 .
[33] M. Maes,et al. Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review. , 2020, Pharmacological research.
[34] Claire K. Ankuda,et al. Family Caregiving at the End of Life and Hospice Use: A National Study of Medicare Beneficiaries , 2020, Journal of the American Geriatrics Society.
[35] P. van Damme,et al. Amyotrophic lateral sclerosis: a clinical review , 2020, European journal of neurology.
[36] T. Finkel,et al. Mitochondria as intracellular signaling platforms in health and disease , 2020, The Journal of cell biology.
[37] David J Newman,et al. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.
[38] M. Heneka,et al. Do infections have a role in the pathogenesis of Alzheimer disease? , 2020, Nature Reviews Neurology.
[39] I. Ferrer,et al. The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain , 2020, Cells.
[40] Enrico Giampieri,et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries , 2020, Gut.
[41] N. Brandon,et al. The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future , 2020, Medicinal research reviews.
[42] Shaoyan Zheng. Protective effect of Polygonatum sibiricum Polysaccharide on D-galactose-induced aging rats model , 2020, Scientific Reports.
[43] Martina Kunkl,et al. T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis , 2020, Cells.
[44] E. Bertini,et al. The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia , 2020, International journal of molecular sciences.
[45] Vijay Kumar,et al. Therapeutic Advances for Huntington’s Disease , 2020, Brain sciences.
[46] S. Ojha,et al. Therapeutic Potential of Baicalein in Parkinson’s Disease: Focus on Inhibition of α-Synuclein Oligomerization and Aggregation , 2019, Synucleins - Biochemistry and Role in Diseases.
[47] Z. Yue,et al. Autophagy and Parkinson's Disease. , 2020, Advances in experimental medicine and biology.
[48] C. Helmstaedter,et al. Anticonvulsant Drugs and Cognition , 2020 .
[49] C. Alméciga-Díaz,et al. Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses , 2019, International journal of molecular sciences.
[50] V. Krajka-Kuźniak,et al. Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain , 2019, International journal of molecular sciences.
[51] A. E. Speck,et al. Role of Adenosine A2A Receptors in the Central Fatigue of Neurodegenerative Diseases , 2019 .
[52] Narttaya Chaiwiang,et al. Microbial dysbiosis and microbiota-gut-retina axis: The lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity. , 2019, Acta microbiologica et immunologica Hungarica.
[53] Y. Jammes,et al. Understanding neuromuscular disorders in chronic fatigue syndrome , 2019, F1000Research.
[54] M. Artola,et al. Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease. , 2019, Current opinion in chemical biology.
[55] Xudong Huang,et al. Contributing Factors of Neurodegeneration in Alzheimer’s Disease , 2019 .
[56] Kumju Youn,et al. Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity , 2019, Nutrients.
[57] G. Grynkiewicz,et al. New Perspectives for Fisetin , 2019, Front. Chem..
[58] ALSUntangled No. 50: Antifungal Therapy , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[59] J. Trojanowski,et al. α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies , 2019, Neuroscience Letters.
[60] R. Maccioni,et al. Neuroinflammation as a Common Feature of Neurodegenerative Disorders , 2019, Front. Pharmacol..
[61] A. Bräuer,et al. Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann–Pick Disease Type C1 , 2019, International journal of molecular sciences.
[62] M. Larhammar,et al. Cell Death and Neurodegeneration. , 2019, Cold Spring Harbor perspectives in biology.
[63] J. Tepe,et al. Proteasome Activation to Combat Proteotoxicity , 2019, Molecules.
[64] Hari Prasad Devkota,et al. Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. , 2019, Chemico-biological interactions.
[65] D. Rhoads,et al. Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease , 2019, Journal of Clinical Microbiology.
[66] R. Truant,et al. DNA Damage Repair in Huntington’s Disease and Other Neurodegenerative Diseases , 2019, Neurotherapeutics.
[67] T. Pandita,et al. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70) , 2019, The Journal of Biological Chemistry.
[68] Z. Illés,et al. Immunological Aspects of Approved MS Therapeutics , 2019, Front. Immunol..
[69] Anirudh Gupta,et al. Charcot-Marie-Tooth: From Molecules to Therapy , 2019, International journal of molecular sciences.
[70] K. Sandhoff,et al. Lysosomal Glycosphingolipid Storage Diseases. , 2019, Annual review of biochemistry.
[71] N. Cech,et al. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. , 2019, Natural product reports.
[72] J. Duarte,et al. Mitochondria and the Brain: Bioenergetics and Beyond , 2019, Neurotoxicity Research.
[73] R. D. de Moura,et al. Antihypertensive effects of the Vitis vinifera grape skin (ACH09) extract consumption elicited by functional improvement of P1 (A1) and P2 (P2X1) purinergic receptors in diabetic and hypertensive rats , 2019, PharmaNutrition.
[74] M. Tremblay,et al. Inflammatory mechanisms in neurodegeneration , 2019, Journal of neurochemistry.
[75] Yunqi Lv,et al. Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis , 2019, Cellular and Molecular Neurobiology.
[76] P. Lajoie,et al. Endoplasmic Reticulum Stress Coping Mechanisms and Lifespan Regulation in Health and Diseases , 2019, Front. Cell Dev. Biol..
[77] Ming Ye,et al. DL-3-n-butylphthalide therapy for Parkinson's disease: A randomized controlled trial. , 2019, Experimental and therapeutic medicine.
[78] D. Eatman,et al. Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells , 2019, Nutrients.
[79] Beth Stevens,et al. Immune Signaling in Neurodegeneration. , 2019, Immunity.
[80] Alexandra B. Nelson,et al. Circuit Mechanisms of Parkinson’s Disease , 2019, Neuron.
[81] V. Parisi,et al. Neuroinflammation as a target for glaucoma therapy , 2019, Neural regeneration research.
[82] S. Snyder,et al. Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities. , 2019, Antioxidants & redox signaling.
[83] R. Gold,et al. Progressive multiple sclerosis: latest therapeutic developments and future directions , 2019, Therapeutic advances in neurological disorders.
[84] Z. Hua,et al. Apoptosis and apoptotic body: disease message and therapeutic target potentials , 2018, Bioscience reports.
[85] Robert W. Taylor,et al. Dissecting the neuronal vulnerability underpinning Alpers’ syndrome: a clinical and neuropathological study , 2018, Brain pathology.
[86] C. Hudon,et al. Polyphenols From Grape and Blueberry Improve Episodic Memory in Healthy Elderly with Lower Level of Memory Performance: A Bicentric Double-Blind, Randomized, Placebo-Controlled Clinical Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[87] J. Mouslim,et al. Medicinal and Aromatic Plants Used in Traditional Treatment of the Oral Pathology: The Ethnobotanical Survey in the Economic Capital Casablanca, Morocco (North Africa) , 2018, Natural Products and Bioprospecting.
[88] Yan Liu,et al. Beneficial effect of compound essential oil inhalation on central fatigue , 2018, BMC Complementary and Alternative Medicine.
[89] E. Acquas,et al. Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS , 2018, Scientific Reports.
[90] S. Rahman,et al. POLG-related disorders and their neurological manifestations , 2018, Nature Reviews Neurology.
[91] G. Breen,et al. Retrotransposons in the development and progression of amyotrophic lateral sclerosis , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[92] Hui-yun Chang,et al. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases , 2018, International journal of molecular sciences.
[93] B. Davidson,et al. Lysosomal storage diseases , 2018, Nature Reviews Disease Primers.
[94] C. Tilikete,et al. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect , 2018, Orphanet Journal of Rare Diseases.
[95] M. Hayden,et al. Therapeutic approaches to Huntington disease: from the bench to the clinic , 2018, Nature Reviews Drug Discovery.
[96] Xiaohui Xu,et al. Protective Effects of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Isolated from Averrhoa Carambola L. (Oxalidaceae) Roots on Neuron Apoptosis and Memory Deficits in Alzheimer's Disease , 2018, Cellular Physiology and Biochemistry.
[97] S. Hickman,et al. Microglia in neurodegeneration , 2018, Nature Neuroscience.
[98] Yifan Feng,et al. Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model , 2018, Life sciences.
[99] Xinghuai Sun,et al. Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma , 2018, Front. Neurosci..
[100] M. Pallàs,et al. Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement , 2018, Molecular Neurobiology.
[101] K. Ochiai,et al. Gingival Periodontal Disease (PD) Level-Butyric Acid Affects the Systemic Blood and Brain Organ: Insights Into the Systemic Inflammation of Periodontal Disease , 2018, Front. Immunol..
[102] Luis Carrasco,et al. Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer’s Disease , 2018, Front. Aging Neurosci..
[103] H. Jiang,et al. Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK , 2018, Neuroscience.
[104] A. Sun. Lysosomal storage disease overview. , 2018, Annals of translational medicine.
[105] Soo-Jin Jeong,et al. The Anti-neuroinflammatory Activity of Tectorigenin Pretreatment via Downregulated NF-κB and ERK/JNK Pathways in BV-2 Microglial and Microglia Inactivation in Mice With Lipopolysaccharide , 2018, Front. Pharmacol..
[106] M. Cavinato,et al. Targeting Protein Quality Control Mechanisms by Natural Products to Promote Healthy Ageing , 2018, Molecules.
[107] V. Baekelandt,et al. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease , 2018, Journal of immunology research.
[108] G. Courtois,et al. The Many Roles of Ubiquitin in NF-κB Signaling , 2018, Biomedicines.
[109] M. Maes,et al. The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications , 2018, Molecular Neurobiology.
[110] P. Pal,et al. Tremor syndromes: A review , 2018, Neurology India.
[111] R. Bedlack. ALSUntangled 44: curcumin , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[112] R. Harding,et al. Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities , 2018, Acta Pharmacologica Sinica.
[113] P. Andrade,et al. Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones , 2018, Chemical science.
[114] D. Reich,et al. Multiple Sclerosis , 2018, The New England journal of medicine.
[115] S. Rai,et al. Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson’s Disease through NF-κB/pAKT Signaling Pathways , 2017, Front. Aging Neurosci..
[116] T. Friede,et al. A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial) , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[117] S. Sarkar,et al. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases , 2017, Essays in biochemistry.
[118] Natalie C. Ward,et al. The cardiovascular health benefits of apples: Whole fruit vs. isolated compounds , 2017 .
[119] C. Chin,et al. Epigenetic Regulatory Mechanisms Induced by Resveratrol , 2017, Nutrients.
[120] Anders Larsson,et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet Neurology.
[121] Yanhua Lu,et al. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis. , 2017, Microbial pathogenesis.
[122] K. Acharya,et al. A Comprehensive Review on Food and Medicinal Prospects of Astraeus hygrometricus , 2017 .
[123] S. Packman,et al. Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial , 2017, American journal of hematology.
[124] S. Hassan,et al. A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase , 2017, Current medicinal chemistry.
[125] A. Ganji,et al. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis , 2017, Immunopharmacology and immunotoxicology.
[126] J. R. Liddell,et al. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration? , 2017, Antioxidants.
[127] Ke-Li Chen,et al. A comparative study of anti-aging properties and mechanism: resveratrol and caloric restriction , 2017, Oncotarget.
[128] R. Gold,et al. Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM , 2017, Neurology and Therapy.
[129] R. Gold,et al. Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. , 2017, Clinical therapeutics.
[130] M. Contin,et al. Mucuna pruriens in Parkinson disease , 2017, Neurology.
[131] J. Flickinger,et al. T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation , 2017, Nature Immunology.
[132] J. Salazar,et al. The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma , 2017, Front. Aging Neurosci..
[133] W. Setzer,et al. In Vitro Testing of Crude Natural Plant Extracts from Costa Rica for Their Ability to Boost Innate Immune Cells against Staphylococcus aureus , 2017, Biomedicines.
[134] C. Dionisi-Vici,et al. The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression , 2017, Metabolic Brain Disease.
[135] C. Whitley,et al. Infantile gangliosidoses: Mapping a timeline of clinical changes. , 2017, Molecular genetics and metabolism.
[136] P. Mouthuy,et al. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) , 2017, Redox biology.
[137] A. Konopka,et al. Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum , 2017, Front. Mol. Neurosci..
[138] S. Kölker,et al. Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases , 2017, Journal of Inherited Metabolic Disease.
[139] L. Joseph,et al. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. , 2017, Chemico-biological interactions.
[140] A. Ciechanover,et al. Protein Quality Control by Molecular Chaperones in Neurodegeneration , 2017, Front. Neurosci..
[141] K. Braun. Preventing cognitive impairment in children with epilepsy , 2017, Current opinion in neurology.
[142] J. Frydman,et al. Protein misfolding in neurodegenerative diseases: implications and strategies , 2017, Translational Neurodegeneration.
[143] S. P. Andrews,et al. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities , 2017, Neuron.
[144] V. Bohr,et al. Cockayne syndrome: Clinical features, model systems and pathways , 2017, Ageing Research Reviews.
[145] J. Lasselin,et al. Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms , 2017, Front. Immunol..
[146] Jayme L. Dahlin,et al. The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.
[147] Dennis W Dickson,et al. Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.
[148] Andrew J. Mocle,et al. Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex , 2016, Human molecular genetics.
[149] A. Bilia,et al. Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs , 2012, Planta Medica.
[150] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis , 2017, Nature Reviews Disease Primers.
[151] Huaxi Xu,et al. Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases , 2016, Front. Aging Neurosci..
[152] J. Julien,et al. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration , 2016, Neurotherapeutics.
[153] Marie-Thérèse Heemels,et al. Neurodegenerative diseases , 2016, Nature.
[154] I. Gazaryan,et al. The status of Nrf2-based therapeutics: current perspectives and future prospects , 2016, Neural regeneration research.
[155] Cheng-Fu Chang,et al. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS , 2016, Journal of Biomedical Science.
[156] J. Atkin,et al. Protein folding alterations in amyotrophic lateral sclerosis , 2016, Brain Research.
[157] Wei Zhang,et al. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms , 2016, Neuropharmacology.
[158] R. Weiskirchen,et al. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? , 2016, Advances in nutrition.
[159] D. Mafra,et al. Brazil nut consumption modulates Nrf2 expression in hemodialysis patients: A pilot study. , 2016, Molecular nutrition & food research.
[160] I. Benjamin,et al. Heat Shock Factor 1 Is a Substrate for p38 Mitogen-Activated Protein Kinases , 2016, Molecular and Cellular Biology.
[161] T. Kielian,et al. Astrocytes and lysosomal storage diseases , 2016, Neuroscience.
[162] Pamela Newland,et al. Central fatigue in multiple sclerosis: a review of the literature , 2016, The journal of spinal cord medicine.
[163] D. Grančai,et al. Immunomodulatory Activity of Leaf Infusions of Selected Cornaceae Species on Human Leukocytes , 2016, Natural product communications.
[164] G. Holmes. Effect of Seizures on the Developing Brain and Cognition. , 2016, Seminars in pediatric neurology.
[165] C. Wolfson,et al. Fatigue and Comorbidities in Multiple Sclerosis. , 2016, International journal of MS care.
[166] Hugo Lövheim,et al. Microbes and Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[167] Xueyang Deng,et al. Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway , 2016 .
[168] J. Quinn,et al. Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. , 2016, Journal of ethnopharmacology.
[169] D. Hirata,et al. Natural thioallyl compounds increase oxidative stress resistance and lifespan in Caenorhabditis elegans by modulating SKN-1/Nrf , 2016, Scientific Reports.
[170] M. Roopesh,et al. Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[171] G. S. Taiwé,et al. Antioxidant and Antifatigue Properties of the Aqueous Extract of Moringa oleifera in Rats Subjected to Forced Swimming Endurance Test , 2016, Oxidative medicine and cellular longevity.
[172] J. Coombes,et al. Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? , 2016, Oxidative medicine and cellular longevity.
[173] N. Yüksel,et al. Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma , 2016, Current eye research.
[174] M. Gharagozloo,et al. Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol. , 2015, Advanced pharmaceutical bulletin.
[175] Luis Carrasco,et al. Different Brain Regions are Infected with Fungi in Alzheimer’s Disease , 2015, Scientific Reports.
[176] G. Kim,et al. The Role of Oxidative Stress in Neurodegenerative Diseases , 2015, Experimental neurobiology.
[177] J. Cooper,et al. Towards a new understanding of NCL pathogenesis. , 2015, Biochimica et biophysica acta.
[178] Daniela Schuster,et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review , 2015, Biotechnology advances.
[179] Shihua Li,et al. Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model , 2015, PloS one.
[180] F. Paul,et al. Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue , 2015, Multiple sclerosis.
[181] G. Macfarlane,et al. Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. , 2015, Rheumatology.
[182] C. Glass,et al. The choreography of neuroinflammation in Huntington's disease. , 2015, Trends in immunology.
[183] P. Lockhart,et al. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels , 2015, Journal of Neurology.
[184] Luis Carrasco,et al. Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.
[185] J. Winkler,et al. Adult neurogenesis in neurodegenerative diseases. , 2015, Cold Spring Harbor perspectives in biology.
[186] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[187] Jun Wang,et al. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway , 2015, Journal of Translational Medicine.
[188] D. Blagojević,et al. Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity. , 2015, The British journal of nutrition.
[189] R. Fischer,et al. Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF , 2015, Oxidative medicine and cellular longevity.
[190] F. Paul,et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. , 2015, The American journal of clinical nutrition.
[191] Yong Tae Kwon,et al. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.
[192] F. R. Papa,et al. The role of endoplasmic reticulum stress in human pathology. , 2015, Annual review of pathology.
[193] M. Berk,et al. The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases , 2015, Molecular Neurobiology.
[194] Pengyu Ren,et al. Allicin protects spinal cord neurons from glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway. , 2015, Food & function.
[195] Jonas Frisén,et al. Adult Neurogenesis in Humans- Common and Unique Traits in Mammals , 2015, PLoS biology.
[196] A. Elsayed,et al. Nigella sativa as an anti-inflammatory and promising remyelinating agent in the cortex and hippocampus of experimental autoimmune encephalomyelitis-induced rats , 2014 .
[197] S. Richer,et al. Resveratrol Based Oral Nutritional Supplement Produces Long-Term Beneficial Effects on Structure and Visual Function in Human Patients , 2014, Nutrients.
[198] J. Jankovic,et al. Chorea associated with Huntington's disease: To treat or not to treat? , 2014, Movement disorders : official journal of the Movement Disorder Society.
[199] F. Zipp,et al. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. , 2014, Cytokine & growth factor reviews.
[200] Jin Han,et al. Echinochrome A Increases Mitochondrial Mass and Function by Modulating Mitochondrial Biogenesis Regulatory Genes , 2014, Marine drugs.
[201] A. L. La Spada,et al. The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy. , 2014, Drug discovery today.
[202] Vincenzo Bonifati,et al. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. , 2014, Biochimica et biophysica acta.
[203] L. Tsai,et al. DNA Damage and Its Links to Neurodegeneration , 2014, Neuron.
[204] Yong-hui Shi,et al. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. , 2014, Food & function.
[205] G. Paolisso,et al. Telomerase activation: A potential key modulator for human healthspan and longevity , 2014, Ageing Research Reviews.
[206] F. A. Resende,et al. An Isoflavone from Dipteryx alata Vogel is Active against the in Vitro Neuromuscular Paralysis of Bothrops jararacussu Snake Venom and Bothropstoxin I, and Prevents Venom-Induced Myonecrosis , 2014, Molecules.
[207] Mal-Soon Shin,et al. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. , 2014, International journal of molecular medicine.
[208] B. Oken,et al. Physiological and functional consequences of caregiving for relatives with dementia , 2014, International Psychogeriatrics.
[209] O. Malm,et al. Brazil Nut (Bertholletia excelsa, H.B.K.) Improves Oxidative Stress and Inflammation Biomarkers in Hemodialysis Patients , 2014, Biological Trace Element Research.
[210] X. Navarro,et al. Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice , 2014, Neurotherapeutics.
[211] Thomas Sommer,et al. Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system. , 2014, Biochimica et biophysica acta.
[212] H. Cai,et al. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson’s disease , 2015, Molecular Neurodegeneration.
[213] Sönke Arlt,et al. Non-Alzheimer's disease—related memory impairment and dementia , 2013, Dialogues in clinical neuroscience.
[214] R. Jaenisch,et al. Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease. , 2013, Cell reports.
[215] M. Filipič,et al. Antigenotoxic effect of Tartary (Fagopyrum tataricum) and common (Fagopyrum esculentum) buckwheat flour. , 2013, Journal of medicinal food.
[216] A. Aderibigbe,et al. Studies on neuropharmacological profile of ethanol extract of Moringa oleifera leaves in mice. , 2013, Journal of ethnopharmacology.
[217] S. Sekaran,et al. Oil palm phenolics confer neuroprotective effects involving cognitive and motor functions in mice , 2013, Nutritional neuroscience.
[218] J. Keller,et al. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. , 2013, Free radical biology & medicine.
[219] M. Unnikrishnan,et al. Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington’s disease in rats , 2013, Drug and chemical toxicology.
[220] J. Sloan,et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. , 2013, Journal of the National Cancer Institute.
[221] H. Mukhtar,et al. Fisetin: a dietary antioxidant for health promotion. , 2013, Antioxidants & redox signaling.
[222] M. Chesselet,et al. Mitochondrial dysfunction and oxidative stress in Parkinson's disease , 2013, Progress in Neurobiology.
[223] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.
[224] James M. Flegal,et al. Influence on longevity of blueberry, cinnamon, green and black tea, pomegranate, sesame, curcumin, morin, pycnogenol, quercetin, and taxifolin fed iso-calorically to long-lived, F1 hybrid mice. , 2013, Rejuvenation research.
[225] Wim Robberecht,et al. The changing scene of amyotrophic lateral sclerosis , 2013, Nature Reviews Neuroscience.
[226] B. Halliwell. The antioxidant paradox: less paradoxical now? , 2013, British journal of clinical pharmacology.
[227] R. Naviaux,et al. Alpers-Huttenlocher syndrome. , 2013, Pediatric neurology.
[228] Y. Chien,et al. Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat , 2012, Orphanet Journal of Rare Diseases.
[229] C. Saslis-Lagoudakis,et al. Phylogenies reveal predictive power of traditional medicine in bioprospecting , 2012, Proceedings of the National Academy of Sciences.
[230] Stefano Necozione,et al. Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study , 2012, Hypertension.
[231] J. Kim,et al. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. , 2012, Journal of medicinal food.
[232] A. Palamara,et al. Infectious Agents and Neurodegeneration , 2012, Molecular Neurobiology.
[233] Dong Hyun Kim,et al. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection , 2012, Neuropharmacology.
[234] W. Setzer,et al. Inhibition of Essential Bacterial Peptidyl-tRNA Hydrolase Activity by Tropical Plant Extracts , 2012, Natural product communications.
[235] M. Schulze,et al. Critical review: vegetables and fruit in the prevention of chronic diseases , 2012, European Journal of Nutrition.
[236] C. Cheroni,et al. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response , 2012, Progress in Neurobiology.
[237] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[238] P. Bergmann,et al. Inflammation-related muscle weakness and fatigue in geriatric patients , 2012, Experimental Gerontology.
[239] Han-Ming Shen,et al. Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy , 2012, Autophagy.
[240] E. Perry,et al. Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging? , 2011, CNS neuroscience & therapeutics.
[241] Khaled Radad,et al. Ginsenosides and Their CNS Targets , 2011, CNS neuroscience & therapeutics.
[242] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[243] G. Perkins,et al. (–)‐Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle , 2011, The Journal of physiology.
[244] A. Sartori,et al. Uncaria tomentosa Aqueous‐ethanol Extract Triggers an Immunomodulation toward a Th2 Cytokine Profile , 2011, Phytotherapy research : PTR.
[245] W. Robberecht,et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease , 2011, Nature Medicine.
[246] Andreas Bracher,et al. Molecular chaperones in protein folding and proteostasis , 2011, Nature.
[247] V. Bohr,et al. DNA repair deficiency in neurodegeneration , 2011, Progress in Neurobiology.
[248] S. Chintala,et al. Curcumin attenuates staurosporine-mediated death of retinal ganglion cells. , 2011, Investigative ophthalmology & visual science.
[249] D. Yoo,et al. Grape seed extract enhances neurogenesis in the hippocampal dentate gyrus in C57BL/6 mice , 2011, Phytotherapy research : PTR.
[250] A. Giese,et al. Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds , 2011, FEBS letters.
[251] Ying Sun,et al. Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse , 2011, PloS one.
[252] Z. Quezado,et al. Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. , 2011, Human molecular genetics.
[253] P. Rasoanaivo,et al. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions , 2011, Malaria Journal.
[254] Jian-Dong Huang,et al. Baicalein Inhibits Formation of α‐Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation , 2011, Chembiochem : a European journal of chemical biology.
[255] K. Tufekci,et al. The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease , 2011, Parkinson's disease.
[256] J. Purcell,et al. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. , 2011, Human molecular genetics.
[257] T. Efferth,et al. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. , 2011, Current drug targets.
[258] P. Elliott,et al. Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis , 2010, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[259] M. Holden,et al. Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers , 2010, BMC medicine.
[260] C. Garrido,et al. Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27* , 2010, The Journal of Biological Chemistry.
[261] D. Green,et al. Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.
[262] J. Dordick,et al. Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.
[263] D. Lockhart,et al. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase , 2010, The FEBS journal.
[264] D. Sulzer,et al. CARGO RECOGNITION FAILURE IS RESPONSIBLE FOR INEFFICIENT AUTOPHAGY IN HUNTINGTON’S DISEASE , 2010, Nature Neuroscience.
[265] S. N. Witt. Hsp70 molecular chaperones and Parkinson's disease. , 2010, Biopolymers.
[266] A. Heiseke,et al. Autophagy, prion infection and their mutual interactions. , 2010, Current issues in molecular biology.
[267] Martin L. Duennwald,et al. A synergistic small molecule combination directly eradicates diverse prion strain structures , 2009, Nature chemical biology.
[268] G. Parenti. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics , 2009, EMBO molecular medicine.
[269] Kirandeep Kaur,et al. Antimalarials from nature. , 2009, Bioorganic & medicinal chemistry.
[270] J. Nam,et al. Anti‐inflammatory activity of p‐coumaryl alcohol‐γ‐O‐methyl ether is mediated through modulation of interferon‐γ production in Th cells , 2009, British journal of pharmacology.
[271] E. Hwang,et al. Effect of naturally occurring hydroxychavicol acetate on the cytokine production in T helper cells. , 2009, International immunopharmacology.
[272] B. Falsini,et al. Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: A short-term study by pattern electroretinogram , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[273] M. McGrath,et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS) , 2009, Journal of Neuroimmunology.
[274] E. Hirsch,et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.
[275] Nilüfer Orhan,et al. Biological activities of Vitis vinifera L. leaves , 2009 .
[276] P. Houghton. Synergy and polyvalence : paradigms to explain the activity of herbal products , 2009 .
[277] D. Dhanasekaran,et al. JNK signaling in apoptosis , 2008, Oncogene.
[278] L. Leocani,et al. Physiopathology of fatigue in Multiple Sclerosis , 2008, Neurological Sciences.
[279] Nicola Brunetti-Pierri,et al. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. , 2008, Molecular genetics and metabolism.
[280] Y. Hwang,et al. The coffee diterpene kahweol induces heme oxygenase‐1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6‐hydroxydopamine‐derived oxidative stress , 2008, FEBS letters.
[281] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[282] Howard Schulman,et al. Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.
[283] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[284] K. Doh-ura,et al. Prophylactic Effect of Dietary Seaweed Fucoidan against Enteral Prion Infection , 2007, Antimicrobial Agents and Chemotherapy.
[285] F. Walker. Huntington's disease , 2007, The Lancet.
[286] M. Fang,et al. Dietary polyphenols may affect DNA methylation. , 2007, The Journal of nutrition.
[287] C. Lorson,et al. Induction of full-length survival motor neuron by polyphenol botanical compounds , 2007, Human Genetics.
[288] Susan Lindquist,et al. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. , 2006, Human molecular genetics.
[289] K. G. Mohandas Rao,et al. Centella asiatica (L.) Leaf Extract Treatment During the Growth Spurt Period Enhances Hippocampal CA3 Neuronal Dendritic Arborization in Rats , 2006, Evidence-based complementary and alternative medicine : eCAM.
[290] Kenjiro Ono,et al. Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro , 2006, Journal of neurochemistry.
[291] Marcy J. Balunas,et al. Drug discovery from medicinal plants. , 2005, Life sciences.
[292] Wieland Peschel,et al. Understanding local Mediterranean diets: a multidisciplinary pharmacological and ethnobotanical approach. , 2005, Pharmacological research.
[293] Christine D. Dijkstra,et al. Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis , 2004, The Journal of experimental medicine.
[294] B. Caughey,et al. Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. , 2004, The Journal of general virology.
[295] A. Chaudhuri,et al. Fatigue in neurological disorders , 2004, The Lancet.
[296] P. Mecocci,et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.
[297] B. Caughey,et al. New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products , 2003, Journal of Virology.
[298] L. Hoey,et al. Bioavailability of phyto-oestrogens , 2003, British Journal of Nutrition.
[299] Mohammad Reza Mohammadi,et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.
[300] G. Kroemer,et al. Heat shock proteins: endogenous modulators of apoptotic cell death. , 2001, Biochemical and biophysical research communications.
[301] C. Pickart,et al. Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.
[302] Y. Sheng,et al. DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[303] J. Turnbull,et al. Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice , 2000, Journal of the Neurological Sciences.
[304] I. Khafagi,et al. The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds. , 2000, Journal of ethnopharmacology.
[305] B. Halliwell. The antioxidant paradox , 2000, The Lancet.
[306] V. Singh,et al. The paradigm of Th1 and Th2 cytokines , 1999, Immunologic research.
[307] Barbara Shukitt-Hale,et al. Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.
[308] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[309] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[310] K. H. Park,et al. Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. , 1996, The Journal of biological chemistry.
[311] A. Krettli,et al. Survey of medicinal plants used as antimalarials in the Amazon. , 1992, Journal of ethnopharmacology.
[312] K. Ono,et al. Differential inhibitory effects of various herb extracts on the activities of reverse transcriptase and various deoxyribonucleic acid (DNA) polymerases. , 1989, Chemical & pharmaceutical bulletin.
[313] C. Malmsten,et al. Prostaglandins, thromboxanes, and leukotrienes in inflammation. , 1986, The American journal of medicine.
[314] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[315] C. Sigurdson,et al. [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.
[316] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.